Development of a quality assurance program for warfarin monitoring in a university hospital

Hospital Pharmacy

Volumn 31, Issue 5, 1996, Pages 527-530

  Howard, Patricia A ^a   Herrlott, Kathy B ^a,b   May, Stephanie G ^a,b  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b Department of Pharmacy Practice ^*

Author keywords

Drug use evaluation; International normalized ratio (INR); Quality assurance program; Warfarin

Indexed keywords

WARFARIN;

ANTICOAGULATION; DRUG MONITORING; EDUCATION PROGRAM; HOSPITAL PHARMACY; INTERNATIONAL STANDARD UNIT; PROTHROMBIN TIME; QUALITY CONTROL; REVIEW; UNIVERSITY HOSPITAL;

EID: 3142571387     PISSN: 00185787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Hirsh J, Dalen JE, Deykin D, et al. Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 1995, 108(Suppl):S231-S246.
2. Ansell JE. Imprecision of the prothrombin time monitoring of oral anticoagulation Am J Clin Pathol 1992; 98.237-239
3. Poller L. Progress in standardization in anticoagulant control. Hematol Rev 1987: 1:223-241.
4. Hirsh J. Oral anticoagulant therapy: Ur-gent need for standardization. Circulation 1992; 86-1332-1335.
5. Morse EE, Panek S, Pisciotto P, et al Reemergence of the international normalized ratio for the standardization of prothrombin time. Ann Clin Lab Sci 1993, 23 184-188.
6. ASHP therapeutic position statement on the use of the international normalized ratio system to monitor oral anticoagulant therapy Am J Health-Syst Pharm 1995, 52:529-531.